Combination Protocols: AOD-9604 can be combined with other metabolic support peptides or compounds, though careful consideration should be given to potential interactions
Phase Initial 4 weeks Daily research amount 300 mcg Volume 0.18 mL U-100 units 18 units Phase Weeks 5-12 Daily research amount 500 mcg Volume 0.30 mL U-100 units 30 units Phase Optional extension Daily research amount 300-500 mcg Volume 0.18-0.30 mL U-100 units 18-30 units This is an anecdotal community structure
Amazon.com: The Peptide Therapy Protocols Bible: Ultimate Guide to BPC-157, TB-500 & Essential Peptides | Evidence-Based Handbook for Weight Loss, Muscle Growth, Anti-Aging & Performance Optimization: 9798346671183: Harrison, Alexander Z.: Books
Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank
We recommend storing serum for further analysis including MMA, or holotranscobalamin and intrinsic factor antibody analysis, and treating the patient immediately with parenteral B12 treatment